Facebook
Instagram
Linkedin
Pinterest
Twitter
Youtube
Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk Free Edition
Sesame Free Edition
Gluten Free Edition
Custom Edition
Allergence
Coupons
About Us
Media Kit
Advertising Guide
Manufacturer Partnership
Subscribe to our newsletter
Contact Us
Resources
FAQ
Tools for Schools
Coupons
Search
Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk Free Edition
Sesame Free Edition
Gluten Free Edition
Custom Edition
Allergence
Coupons
About Us
Media Kit
Advertising Guide
Manufacturer Partnership
Subscribe to our newsletter
Contact Us
Resources
FAQ
Tools for Schools
Coupons
Search
Tag: Institute for Clinical and Economic Review (ICER)
A Review of Online Anaphylaxis Training Offered by the American Red...
Dave Bloom
-
2021/02/04
The best anaphylaxis readiness training is from the patient's doctor. For others, a training course provides an option.
Fare Responds to Final ICER Review of Breakthrough Peanut Allergy Therapies
News Wire ~ 3rd Party Press Release
-
2019/07/11
FARE expresses its deep concerns with the final evidence report on two breakthrough peanut allergy therapies issued Wednesday by ICER.
Asthma and Allergy Foundation of America Responds to Premature ICER Review...
Dave Bloom
-
2019/07/11
The AAFA addresses concerns regarding the Final Evidence Report released by the ICER.
Aimmune Statement on Institute for Clinical and Economic Review (ICER) Final...
News Wire ~ 3rd Party Press Release
-
2019/07/11
Exclusion of long-term desensitization and patient quality-of-life data by ICER fails to recognize the full value AR101 immunotherapy can deliver to the peanut allergy community.
ICER’s Final Report on Peanut Allergy Treatments: Clinical Evidence Does Not...
News Wire ~ 3rd Party Press Release
-
2019/07/11
The report evaluates Viaskin® Peanut and AR101, as well as non-commercialized oral immunotherapy (OIT).
Asthma and Allergy Foundation of America Elevates Patient Voice in ICER...
News Wire ~ 3rd Party Press Release
-
2019/06/14
Affirms Burden of Food Allergies on Families, Patients, and Caregivers.
Joint Statement on Peanut Allergy Therapy Review
News Wire ~ 3rd Party Press Release
-
2019/06/13
Organizations representing patients and allergists urge ICER to adopt a more patient-driven approach to assessing immunotherapies for peanut allergy.
Non-Profit Institute to Review Benefits of Commercial, Private Practice Immunotherapies for...
Dave Bloom
-
2018/11/28
An independent review of the value, costs and effectiveness of Viaskin Peanut, AR101, and private practice peanut OIT.